GRAIL

GRAIL Galleri Consultant (Santa Monica, CA) #4355

California, United States

Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, Biotechnology, Medical Devices, DiagnosticsIndustries

About GRAIL

Our mission is to detect cancer early, when it can be cured. We are working to change the trajectory of cancer mortality and bring stakeholders together to adopt innovative, safe, and effective technologies that can transform cancer care. We are a healthcare company, pioneering new technologies to advance early cancer detection. We have built a multi-disciplinary organization of scientists, engineers, and physicians and we are using the power of next-generation sequencing (NGS), population-scale clinical studies, and state-of-the-art computer science and data science to overcome one of medicine’s greatest challenges. GRAIL is headquartered in Menlo Park, California, with locations in Washington, D.C., North Carolina, and the United Kingdom. It is supported by leading global investors and pharmaceutical, technology, and healthcare companies. For more information, please visit grail.com.

We’re building a world-class team to take on one of healthcare’s most important challenges. Are you ready to join us?

Employment Type: Full-Time

GRAIL Galleri Consultant (GGC)

This is a great opportunity to join the growing commercial team at GRAIL, as a GRAIL Galleri Consultant (GGC), working hand in hand with sales leadership and internal stakeholders to execute the go to market sales strategy for GRAIL’s revolutionary MCED (multi-cancer early detection) product Galleri.

This is a customer-focused position that requires a “market builder” mindset. A successful GGC acts with urgency and passion to engage physicians and their staff to think differently about cancer screening and change the way they practice, integrating MCED technology into their office workflow, and consistently offering it to appropriate patients with the goal to identify more cancers sooner.

GRAIL is the first company in the world to bring MCED technology to patients and clinicians - this is a rare opportunity in one's career! This position is field based and will oversee the Santa Monica Territory.

The GGC role is an in-person selling role, with the expectation that candidates spend the majority of their time (>85%) making in-person visits to targeted physician practices, planning and supporting events, and executing on Company initiatives.

Candidates must reside within the territory in one of these locations- Santa Monica, Culver City, or surrounding areas.

Responsibilities

  • Be part of a best-in-class commercial organization
  • Report directly to a GRAIL District Manager
  • Prospect and target primary care practices in your territory to generate interest in Galleri and identify/onboard early adopter customers
  • Represent a diverse team of professionals to enhance our competitiveness and innovation
  • Be part of a team and collaborate with internal stakeholders to succeed in creating a new paradigm in cancer screening
  • Work with executive sales leadership, marketing, customer service, billing, and other customer-facing functions to provide “on the ground” feedback that will help shape our strategies and execution plans
  • Develop and implement a business plan to support your territory’s growth
  • Demonstrate and leverage a deep understanding of the Laboratory Developed Test (LDT) market, competitive landscape and current cancer screening options, in the effective execution of sales activities and growth
  • Meet or exceed sales goals by increasing breadth and depth of prescribing, maximize the impact of promotional budgets, and execute the national sales strategy in accordance with GRAIL standards and management expectations.
  • Identify opportunities in the marketplace, share best practices, and proactively communicate successful selling strategies to peers, management, cross-functional partners, and members of the Commercial Team
  • Manage implementation of all promotional activities to support sales and marketing strategies, in accordance with high industry standards and company policies
  • Collaborate with Medical Science Liaisons (MSLs) to educate providers on the science and studies that sup

Skills

Sales Strategy
Customer Engagement
Physician Engagement
Healthcare Sales
Cancer Screening
MCED Technology
Market Building
Next-Generation Sequencing (NGS)
Computer Science
Data Science

GRAIL

Develops blood tests for early cancer detection

About GRAIL

GRAIL focuses on improving cancer detection through advanced blood tests that identify cancer at its earliest stages, enhancing treatment success rates. The company utilizes high-intensity sequencing to analyze tumor genome data, employing algorithms and deep learning to extract actionable information for early cancer detection. GRAIL differentiates itself from competitors by its commitment to large-scale clinical studies that validate the effectiveness of its tests. The primary goal is to reduce global cancer mortality by enabling early diagnosis, making the disease more treatable.

Menlo Park, CaliforniaHeadquarters
2016Year Founded
$1,765.5MTotal Funding
ACQUISITIONCompany Stage
Biotechnology, HealthcareIndustries
1,001-5,000Employees

Benefits

Outstanding People - Join a team of passionate and dedicated professionals, committed to collaboration, education, and proactive problem-solving.
Strong Compensation - We offer competitive salaries and savings plans to provide for long-term financial planning.
Complete Health Coverage - Take advantage of comprehensive health coverage, with medical, dental and vision, to keep you and your family healthy.
Work-Life Balance - Make everyday life more manageable with flexible time off – we trust you to do great work and take time for yourself.

Risks

Potential overdiagnosis could impact the perceived value of GRAIL's tests.
Significant net losses may affect investor confidence and long-term sustainability.
High test costs may limit accessibility in markets with less healthcare funding.

Differentiation

GRAIL uses high-intensity sequencing for early cancer detection via blood tests.
The Galleri test screens for over 50 cancers with a single blood draw.
GRAIL's tests are supported by large-scale clinical studies ensuring reliability.

Upsides

Collaborations with platforms like Function Health expand Galleri test accessibility.
Revenue from Galleri grew 52% year-over-year, indicating strong market demand.
GRAIL's technology aligns with trends in personalized and preventative medicine.

Land your dream remote job 3x faster with AI